Target intelligence / Profile preview

GOT1 divergent transcript (GOT1-DT)

Target: GOT1-DT
Molecular classification: Other, Long non-coding RNA (lncRNA)

Overview

GOT1 divergent transcript (GOT1-DT) is a long non-coding RNA (lncRNA) gene located near the protein-coding GOT1 gene. As a divergent lncRNA, GOT1-DT typically initiates transcription in the opposite direction from an adjacent protein-coding gene (here, GOT1) and is classified as part of the lncRNA family[4][5]. There is currently no functional or disease association information available for GOT1-DT, and it is not recognized as a direct therapeutic target, receptor, enzyme, transporter, or signaling molecule in current biomedical literature[4][5].

Other names: GOT1-DTGOT1 divergent transcript

Biological functions

Unknown, but belongs to the class of divergent lncRNAs[4][5]

Beyond the preview

Go deeper on GOT1 divergent transcript (GOT1-DT).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Explore the programs pursuing this target and their development progress.

Drug candidates
Developers
Development stage

Clinical trials

Follow the clinical studies evaluating therapies directed at this target.

Trial design
Status
Readouts

Competitive landscape

Compare approaches across drug candidates, modalities, and indications.

Programs
Modalities
Indications

Literature & evidence

Investigate the research and source evidence behind target biology and development.

Publications
Sources
Analysis

Patents

Explore patent activity around therapies and technologies addressing this target.

Patents
Assignees
Technologies

Research & analysis

Connect target biology, drug development, and emerging evidence in your research.

Biology
Development news
Analysis

Bring the full picture into focus.

See how Gosset can support your research on GOT1 divergent transcript (GOT1-DT).

Explore the full profile